Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Todd M Morgan

Showing results (81-90 of 307) with videos related to

Pageof 31
Sort By:
American Journal of Clinical Pathology|February 22, 2024
A longitudinal mixed-methods study of pathology explanation clinics in patients with newly diagnosed localized prostate cancerSarah E Bergholtz, Sophia R Kurnot, Esha Elahi, et al.
European Urology|December 19, 2017
A Multigene Signature Based on Cell Cycle Proliferation Improves Prediction of Mortality Within 5 Yr of Radical Nephrectomy for Renal Cell CarcinomaTodd M Morgan, Rohit Mehra, Placede Tiemeny, et al.
Cancer Science|November 24, 2020
Multigene model for predicting metastatic prostate cancer using circulating tumor cells by microfluidic magnetophoresisHyungseok Cho, Jae Il Chung, Jinho Kim, et al.
Journal of Cellular Biochemistry|May 7, 2016
Growth Arrest-Specific 6 (GAS6) Promotes Prostate Cancer Survival by G<sub>1</sub> Arrest/S Phase Delay and Inhibition of Apoptosis During Chemotherapy in Bone MarrowEunsohl Lee, Ann M Decker, Frank C Cackowski, et al.
Urology Case Reports|June 2, 2017
Rare Presentation of Metastatic Cystic Trophoblastic Tumor in a Patient Without Prior ChemotherapyMichael L Wang, Jonathan B McHugh, Alon Z Weizer, et al.
BJU International|September 25, 2018
Pathological upgrading at radical prostatectomy for patients with Grade Group 1 prostate cancer: implications of confirmatory testing for patients considering active surveillanceDeborah R Kaye, Ji Qi, Todd M Morgan, et al.
European Urology Focus|July 21, 2017
Individual Patient Data Analysis of Randomized Clinical Trials: Impact of Black Race on Castration-resistant Prostate Cancer OutcomesDaniel E Spratt, Yu-Wei Chen, Brandon A Mahal, et al.
Urology|May 10, 2011
Urinary collecting system invasion is a predictor for overall and disease-specific survival in locally invasive renal cell carcinomaChristopher B Anderson, Peter E Clark, Todd M Morgan, et al.
The Journal of Urology|October 23, 2012
Volume outcomes of cystectomy--is it the surgeon or the setting?Todd M Morgan, Daniel A Barocas, Kirk A Keegan, et al.
JAMA Network Open|February 2, 2019
Individual and Population Comparisons of Surgery and Radiotherapy Outcomes in Prostate Cancer Using Bayesian Multistate ModelsLauren J Beesley, Todd M Morgan, Daniel E Spratt, et al.
Pageof 31

Showing results (81-90 of 307) with videos related to

Sort By:
Pageof 31
American Journal of Clinical Pathology|February 22, 2024
A longitudinal mixed-methods study of pathology explanation clinics in patients with newly diagnosed localized prostate cancerSarah E Bergholtz, Sophia R Kurnot, Esha Elahi, et al.
European Urology|December 19, 2017
A Multigene Signature Based on Cell Cycle Proliferation Improves Prediction of Mortality Within 5 Yr of Radical Nephrectomy for Renal Cell CarcinomaTodd M Morgan, Rohit Mehra, Placede Tiemeny, et al.
Cancer Science|November 24, 2020
Multigene model for predicting metastatic prostate cancer using circulating tumor cells by microfluidic magnetophoresisHyungseok Cho, Jae Il Chung, Jinho Kim, et al.
Journal of Cellular Biochemistry|May 7, 2016
Growth Arrest-Specific 6 (GAS6) Promotes Prostate Cancer Survival by G<sub>1</sub> Arrest/S Phase Delay and Inhibition of Apoptosis During Chemotherapy in Bone MarrowEunsohl Lee, Ann M Decker, Frank C Cackowski, et al.
Urology Case Reports|June 2, 2017
Rare Presentation of Metastatic Cystic Trophoblastic Tumor in a Patient Without Prior ChemotherapyMichael L Wang, Jonathan B McHugh, Alon Z Weizer, et al.
BJU International|September 25, 2018
Pathological upgrading at radical prostatectomy for patients with Grade Group 1 prostate cancer: implications of confirmatory testing for patients considering active surveillanceDeborah R Kaye, Ji Qi, Todd M Morgan, et al.
European Urology Focus|July 21, 2017
Individual Patient Data Analysis of Randomized Clinical Trials: Impact of Black Race on Castration-resistant Prostate Cancer OutcomesDaniel E Spratt, Yu-Wei Chen, Brandon A Mahal, et al.
Urology|May 10, 2011
Urinary collecting system invasion is a predictor for overall and disease-specific survival in locally invasive renal cell carcinomaChristopher B Anderson, Peter E Clark, Todd M Morgan, et al.
The Journal of Urology|October 23, 2012
Volume outcomes of cystectomy--is it the surgeon or the setting?Todd M Morgan, Daniel A Barocas, Kirk A Keegan, et al.
JAMA Network Open|February 2, 2019
Individual and Population Comparisons of Surgery and Radiotherapy Outcomes in Prostate Cancer Using Bayesian Multistate ModelsLauren J Beesley, Todd M Morgan, Daniel E Spratt, et al.
Pageof 31